A carregar...
Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot placebo-controlled trial
OBJECTIVE: Obsessive-compulsive disorder (OCD) affects approximately 2.5% of the population and is associated with significant morbidity. Many patients receive little benefit from the best available treatments, and even those who do respond often suffer from significant residual symptoms. Convergent...
Na minha lista:
| Publicado no: | J Clin Psychiatry |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4560666/ https://ncbi.nlm.nih.gov/pubmed/26214725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.14m09123 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|